Flow cytometric analysis does not reliably differentiate benign from malignant phaeochromocytoma

被引:11
作者
Heaney, AP
ORourke, D
Arthur, K
Beatty, OL
Russell, CFJ
Sloan, JM
Hamilton, P
Atkinson, AB
机构
[1] ROYAL VICTORIA HOSP,SIR GEORGE E CLARK METAB UNIT,BELFAST BT12 6BA,ANTRIM,NORTH IRELAND
[2] ROYAL VICTORIA HOSP,DEPT PATHOL,BELFAST BT12 6BA,ANTRIM,NORTH IRELAND
[3] ROYAL VICTORIA HOSP,DEPT ENDOCRINE SURG,BELFAST BT12 6BA,ANTRIM,NORTH IRELAND
关键词
D O I
10.1046/j.1365-2265.1996.624448.x
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
BACKGROUND AND OBJECTIVE The differentiation of benign from malignant phaeochromocytoma is difficult, We have examined whether the use of flow cytometric determination of nuclear DNA content would be useful as a predictor of malignant behaviour in patients with phaeochromocytoma as some previous studies had suggested that a diploid cytometric DNA pattern indicated benign disease. DESIGN AND PATIENTS DNA flow cytometry was performed on phaeochromocytoma tissue from 36 patients (19 female, 17 male; mean age at presentation 39.5 years), The results were correlated with clinical outcome after prolonged follow-up. MEASUREMENTS DNA histograms were constructed following nuclear suspension analysis. RESULTS Of 26 patients followed up for more than 5 years after initial removal of primary phaeochromocytoma, three have died from malignant recurrence, In these patients a diploid DNA cytometric pattern was observed in two and an aneuploid pattern in one. Twenty-one patients are still alive, DNA cytometry showed a diploid pattern in the one patient who developed recurrent phaeochromocytoma 4 years after removal of a primary tumour. CONCLUSION In this study, three of nine patients with an apparently benign diploid cytometric pattern subsequently developed recurrent disease. Routine use of DNA flow cytometry did not reliably differentiate benign from malignant phaeochromocytoma. Prolonged clinical and biochemical follow-up is still necessary for all patients with this condition.
引用
收藏
页码:233 / 238
页数:6
相关论文
共 22 条
[1]   FLOW CYTOMETRIC DETERMINATION OF NUCLEAR-DNA CONTENT IN BENIGN ADRENAL PHEOCHROMOCYTOMAS [J].
AMBERSON, JB ;
VAUGHAN, ED ;
GRAY, GF ;
NAUS, GJ .
UROLOGY, 1987, 30 (02) :102-104
[2]   THE INFLUENCE OF TUMOR-CELL DNA ABNORMALITIES ON SURVIVAL IN COLORECTAL-CANCER [J].
ARMITAGE, NC ;
ROBINS, RA ;
EVANS, DF ;
TURNER, DR ;
BALDWIN, RW ;
HARDCASTLE, JD .
BRITISH JOURNAL OF SURGERY, 1985, 72 (10) :828-830
[3]  
BEATTY OL, IN PRESS EUROPEAN J
[4]   PROGNOSTIC-SIGNIFICANCE OF NUCLEAR-DNA CONTENT IN PHEOCHROMOCYTOMA [J].
COPE, C ;
DELBRIDGE, L ;
PHILIPS, J ;
FRIEDLANDER, M .
AUSTRALIAN AND NEW ZEALAND JOURNAL OF SURGERY, 1991, 61 (09) :695-698
[5]   FLOW-CYTOMETRY USING PARAFFIN-EMBEDDED TISSUE - 5 YEARS ON [J].
HEDLEY, DW .
CYTOMETRY, 1989, 10 (03) :229-241
[6]   METHOD FOR ANALYSIS OF CELLULAR DNA CONTENT OF PARAFFIN-EMBEDDED PATHOLOGICAL MATERIAL USING FLOW-CYTOMETRY [J].
HEDLEY, DW ;
FRIEDLANDER, ML ;
TAYLOR, IW ;
RUGG, CA ;
MUSGROVE, EA .
JOURNAL OF HISTOCHEMISTRY & CYTOCHEMISTRY, 1983, 31 (11) :1333-1335
[7]   CONVENTION ON NOMENCLATURE FOR DNA CYTOMETRY [J].
HIDDEMANN, W ;
SCHUMANN, J ;
ANDREEF, M ;
BARLOGIE, B ;
HERMAN, CJ ;
LEIF, RC ;
MAYALL, BH ;
MURPHY, RF ;
SANDBERG, AA .
CANCER GENETICS AND CYTOGENETICS, 1984, 13 (02) :181-183
[8]   FLOW CYTOMETRIC DNA HISTOGRAMS OF PARAFFIN-EMBEDDED PHEOCHROMOCYTOMAS [J].
HOSAKA, Y ;
ASO, Y ;
RAINWATER, LM ;
GRANT, CS ;
FARROW, GM ;
VANHEERDEN, JA ;
LIEBER, MM .
UROLOGIA INTERNATIONALIS, 1991, 47 :100-103
[9]  
HOSAKA Y, 1986, SURGERY, V100, P1003
[10]  
Jung Woo-Hee, 1992, Yonsei Medical Journal, V33, P249